NCT04078373Recruiting
Urinary Disorders in Subacute Patients After Stroke
Assessment and Treatment of Urinary Disorders in Patients in the Subacute Phase After Stroke
Source: ClinicalTrials.gov · Last updated 15 Jun 2026
Brief summary (registry, in English)
This observational study will address urinary disorders in subacute stroke patients. Patients without and with urinary disorders will be compared, and treatment outcome will be assessed among the latter.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 250 (estimated)
- First submitted
- 29 Aug 2019
- Start date
- Jun 2019
- Primary completion date
- Oct 2026
- Lead sponsor
- University Rehabilitation Institute, Republic of Slovenia
- Diseases
- Stroke
- NCT number
- NCT04078373
What you commit to
- Study type: Observational
- Planned participants: 250
- From Jun 2019 to the primary completion date, Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- previous brain injury or other brain disease;
- previous bladder or prostate surgery;
Other illness
- incontinence before stroke;
- inability to ambulate before stroke;
- terminal disease with expected survival less than three months.
Who the study is looking for
- subacute patients after ischaemic or hemorrhagic stroke;
- direct transfer from acute hospital to complex inpatient rehabilitation at our Institute.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Rehabilitation Institute, Republic of Slovenia Coordinator of this site? Confirm its status | Ljubljana | Slovenia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.